Management


 

Prof. Mimi Tang

Prof. Mimi Tang

Chief Executive Officer

Scientific Founder and global thought leader in allergy. 25+ years experience as a physician scientist specialising in pediatric allergy immunology. Professor Tang has authored over 330 scientific publications in the field and ranks in the top 1% of highly cited researchers in the field of Immunology (Web of Science).
DR MARK HASLETON

DR MARK HASLETON

Clinical and Commercial Operations

Over 20 years of global biotech / device and pharma experience. Established record of delivering innovative solutions that improve outcomes for patients, healthcare providers and families. Dr Hasleton has held management positions at Bristol Myers-Squibb and Teva Pharmaceuticals, and has a doctorate in molecular biology from Imperial College London.
Cameron Jones

Cameron Jones

Chief Financial Officer – Consultant

18+ years experience in strategic planning and functional execution of regional and global Phase 1-4 pharmaceutical clinical trials for large pharmaceutical companies and contract research organizations.
Kathy Harrison

Kathy Harrison

Director, Intellectual Property

25+ years experience in Australian biotech companies and 9 years in patent attorney practice. Strategic expertise in drug development and intellectual property portfolios.
Bronwyn Pollock

Bronwyn Pollock

Product Development Technical Services - Consultant

Biotech and pharmaceutical professional with 25+ years experience in drug development, quality and program management, submissions to EMA and US FDA.  Responsible for all aspects of drug development
Lesley White

Lesley White

Regulatory Affairs – Consultant

Regulatory professional with 26+ years experience in global pharmaceutical regulation and submissions to US FDA, EMA and regulators in other regions including Japan, SE Asia, Middle East.